100 results
8-K
EX-99.1
URGN
UroGen Pharma Ltd
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
in the public offering. There can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms
8-K
EX-1.1
URGN
UroGen Pharma Ltd
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
and records and maintains a system of internal accounting controls sufficient to provide reasonable assurance
that: (i) transactions are executed
424B5
URGN
UroGen Pharma Ltd
18 Jun 24
Prospectus supplement for primary offering
5:05pm
for use in connection with this offering. Neither we nor the underwriters take any responsibility for, and can provide no assurance as to the reliability … there can be no assurance in this regard. Further, the IRS has determined that the U.S.-Israel Tax Treaty is satisfactory for purposes
424B5
URGN
UroGen Pharma Ltd
17 Jun 24
Prospectus supplement for primary offering
4:19pm
. Neither we nor the underwriters take any responsibility for, and can provide no assurance as to the reliability of, any information that others may … of, the U.S.-Israel Tax Treaty, although there can be no assurance in this regard. Further, the IRS has determined that the U.S.-Israel Tax Treaty
8-K
URGN
UroGen Pharma Ltd
13 Jun 24
Regulation FD Disclosure
10:51am
no assurance that such expectations and assumptions will prove to be correct. Forward-looking statements include all statements that are not historical
8-K
cry7dwo gk6ot34
1 Mar 24
Regulation FD Disclosure
7:00am